Agilent Technologies News

Declining Stock and Solid Fundamentals: Is The Market Wrong About Agilent Technologies, Inc. (NYSE:A)?

Yahoo FinanceApr 26 08:00 ET

Express News | NYSE Order Imbalance 76186.0 Shares on Buy Side

Moomoo 24/7Apr 24 15:50 ET

Express News | Agilent Shares Are Trading Higher in Possible Sympathy With Danaher, Which Reported Better-than-expected Q1 Financial Results

Moomoo 24/7Apr 23 08:48 ET

Danaher Gains as Q1 Results Exceed Expectations

Seeking AlphaApr 23 06:58 ET

Express News | Agilent Technologies Inc : Bernstein Raises Target Price to $130 From $127

Moomoo 24/7Apr 23 05:21 ET

Global Chromatography Software Market Analysis & Forecast 2024-2034, Featuring Bruker, Waters, Restek, Gilson, Shimadzu, Cytiva, Scion Instruments, DataApex, KNAUER and Agilent Technologies

Yahoo FinanceApr 23 03:51 ET

Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it might be obvious that you need to consider debt, whe

Simply Wall StApr 20 10:01 ET

Reitmans (Canada) Limited Reports Fiscal 2024 and Fourth Quarter Fiscal 2024 Financial Results

Stockhouse Apr 18 16:30 ET

Global Biochips Market Size and Share to Grow by 2030, Accesses DelveInsight | Key Players in the Market - Thermo Fisher Scientific, Agilent Technologies, GE Healthcare, Qiagen, Abbott, Hoffmann La-Roche, Cepheid

New York, USA, April 18, 2024 (GLOBE NEWSWIRE) -- Global Biochips Market Size and Share to Grow by 2030, Accesses DelveInsight | Key Players in the Market - Thermo Fisher Scientific, Agilent Technologies, GE

GlobeNewswireApr 18 13:00 ET

PacBio Cut to Neutral at Goldman Sachs After Guidance Cut

Seeking AlphaApr 18 08:15 ET

Express News | Agilent Technologies Inc : BofA Global Research Raises Price Objective to $145 From $141

Moomoo 24/7Apr 17 06:23 ET

Agilent Receives Scientists' Choice Awards for Sustainability

Business WireApr 16 08:00 ET

Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years

Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 3.06% on an annualized basis producing an average annual return of 13.59%. Currently, Agilent Technologies has a mar

BenzingaApr 15 11:30 ET

Express News | Agilent Receives European Ivdr Class C Certification for Genetisure Dx Postnatal Assay

Moomoo 24/7Apr 15 08:02 ET

Global Analytical Standards Market Forecast at $2.08 Billion by 2030, Dominated by Merck, Waters Corporation, and Agilent Technologies - Strict Quality Regulations Driving the Market

Yahoo FinanceApr 11 11:24 ET

Agilent Is Maintained at Underweight by Barclays

Agilent Is Maintained at Underweight by Barclays

Dow JonesApr 10 15:46 ET

Barclays Maintains Underweight on Agilent Technologies, Raises Price Target to $135

Barclays analyst Luke Sergott maintains Agilent Technologies with a Underweight and raises the price target from $125 to $135.

Analyst UpgradesApr 10 15:36 ET

(A) - Analyzing Agilent Technologies's Short Interest

Agilent Technologies's (NYSE:A) short percent of float has risen 31.43% since its last report. The company recently reported that it has 3.58 million shares sold short, which is 1.38% of all regular s

BenzingaApr 10 11:00 ET

Transcenta Partners With Agilent to Develop Claudin18.2 Companion Diagnostic

Transcenta Holding (HKG:6628) announced a collaboration with California-based Agilent Technologies, according to a filing with the Hong Kong Exchange on Tuesday. Under the tie-up, the parties will joi

MT NewswiresApr 9 09:18 ET

Chuangsheng Group-B (06628) announced the latest business progress in collaborating with Agilent to develop CLDN18.2 companion diagnostic reagents to support global phase III clinical trials of Osemitamab (TST001)

Chuangsheng Group-B (06628) issued an announcement to cooperate with Agilent Technologies to develop Claudin18.2...

Zhitong FinanceApr 8 18:48 ET